Tredegar (TG) Q1 2026 earnings summary

Executive summary

• Net income from continuing operations rose to $5.1M ($0.15 per diluted share) in Q1 2026 from $0.7M ($0.02 per share) in Q1 2025, driven by higher sales and lower SG&A and interest expenses.

• Net income from ongoing operations was $5.0M ($0.15 per share), up from $3.6M ($0.10 per share) year-over-year.

• Consolidated EBITDA from ongoing operations was $11.7M, up from $11.5M in Q1 2025.

• Performance was primarily driven by Aluminum Extrusions, offset by softness in High Performance Films.

• The company completed the sale of its flexible packaging films business (Terphane) in late 2024; all historical results for Terphane are now presented as discontinued operations.

Financial highlights

• Q1 2026 sales were $186.5M, up from $164.7M in Q1 2025.

• Gross profit margin declined to 12.6% from 14.3% year-over-year.

• Net debt stood at $30.7M as of March 31, 2026, up from $28.4M at year-end 2025.

• Cash flows from operations were $2.0M in Q1 2026, compared to net cash used of $5.0M in Q1 2025.

• Total debt increased to $46.3M, with cash and equivalents at $15.6M.

Outlook and guidance

• Capital expenditures for 2026 are projected at $20M for Aluminum Extrusions and $2M for High Performance Films.

• Management sees substantial opportunities for operational excellence, cost reduction, and long-term value creation.

• Capital spending is expected to align with depreciation and amortization, supporting maintenance and efficiency initiatives.

• Management believes current liquidity and borrowing capacity are sufficient for at least the next 12 months.